re7341199
/portal/roactemra
RoACTEMRA.com
skip to the content
Search for...
Search for...
Home
About ACTEMRA
Pharmacology
Mechanism of Action
Drug Interactions
Dosage and Administration
Indication
Phase III Trials
AMBITION
OPTION
TOWARD
LITHE
RADIATE
Efficacy
MTX-naïve Patients
DMARD Inadequate Responders
OPTION
TOWARD
LITHE
Anti-TNF Inadequate Responders
Safety and Tolerability
Contraindications
Warnings and Precautions for use
About RA
Disease burden
Aetiology
Signs, symptoms and co-morbidities
Pathophysiology
The role of IL-6
Diagnosing and monitoring
Current treatment strategies
Resources
Physician Resources
DAS28 calculator
Congress Highlights
EULAR
ACR
Key Publication Summaries
Mihara Clin Immunol 2001 summary
Nishimoto J Rheumatol 2003 summary
Nemeth J Clin Invest 2004 summary
Nishimoto Arthritis Rheum 2004 summary
Maini Arthritis Rheum 2006 summary
Nishimoto Ann Rheum Dis 2007 summary
Smolen Lancet 2008 summary
Genovese Arthritis Rheum 2008 summary
Emery Ann Rheum Dis 2008 summary
Choy & Sattar Ann Rheum Dis 2009 summary
Nishimoto Ann Rheum Dis 2009 summary
Nishimoto Mod Rheumatol 2009 summary
Jones Ann Rheum Dis 2010 summary
Bergman Semin Arthritis Rheum 2010 summary
Kremer Arthritis Rheum 2010 Summary
Rau Clin Exp Rheumatol 2010 Summary
Burmester Ann Rheum Dis 2010 Summary
Image Library
All images
ACTEMRA for sJIA
About sJIA
Disease burden
Complications of sJIA
Pathophysiology of sJIA
Role of IL-6
sJIA Resources
Sitemap
Glossary
Contact
Home
About ACTEMRA
Resources
About RA
ACTEMRA for sJIA
